Industry: Pharma & Healthcare
Published Date: 2025-01-04
Pages: 101 Pages
Report ld: 3521687
Request Sample
Customized Report
The global market for Parenteral Excipients was estimated to be worth US$ 1547 million in 2023 and is forecast to a readjusted size of US$ 2177 million by 2030 with a CAGR of 5.4% during the forecast period 2024-2030.
Parenteral excipients are excipients used in parenteral drug delivery systems. Parenteral drug delivery systems typically include intravenous injection, intramuscular injection, subcutaneous injection, and other routes of administration for directly delivering drugs into the bloodstream or tissues to achieve therapeutic effects. Parenteral excipients play multiple critical roles in parenteral drug delivery systems, such as increasing drug solubility, stability, bioavailability, and safety. Common parenteral excipients include glucose, sodium chloride, and glycerol. The selection and use of these excipients need to be determined based on the characteristics of the drugs and the route of administration to ensure the effectiveness and safety of the drugs.
North American market for Parenteral Excipients was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Parenteral Excipients was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Parenteral Excipients was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Parenteral Excipients include Merck, Ashland, Roquette, Croda Pharma, BASF, Evonik, Seppic, Lubrizol, Pfanstiehl, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Parenteral Excipients, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Parenteral Excipients by region & country, by Type, and by Application.
The Parenteral Excipients market size, estimations, and forecasts are provided in terms of sales volume (Tons) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Parenteral Excipients.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Parenteral Excipients manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Parenteral Excipients in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Parenteral Excipients in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Parenteral Excipients Product Introduction
1.2 Global Parenteral Excipients Market Size Forecast
1.2.1 Global Parenteral Excipients Sales Value (2019-2030)
1.2.2 Global Parenteral Excipients Sales Volume (2019-2030)
1.2.3 Global Parenteral Excipients Sales Price (2019-2030)
1.3 Parenteral Excipients Market Trends & Drivers
1.3.1 Parenteral Excipients Industry Trends
1.3.2 Parenteral Excipients Market Drivers & Opportunity
1.3.3 Parenteral Excipients Market Challenges
1.3.4 Parenteral Excipients Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Parenteral Excipients Players Revenue Ranking (2023)
2.2 Global Parenteral Excipients Revenue by Company (2019-2024)
2.3 Global Parenteral Excipients Players Sales Volume Ranking (2023)
2.4 Global Parenteral Excipients Sales Volume by Company Players (2019-2024)
2.5 Global Parenteral Excipients Average Price by Company (2019-2024)
2.6 Key Manufacturers Parenteral Excipients Manufacturing Base and Headquarters
2.7 Key Manufacturers Parenteral Excipients Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Parenteral Excipients
2.9 Parenteral Excipients Market Competitive Analysis
2.9.1 Parenteral Excipients Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Parenteral Excipients Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Parenteral Excipients as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Solubilizers
3.1.2 Bulker
3.1.3 Preservatives
3.1.4 Solvents
3.1.5 Others
3.2 Global Parenteral Excipients Sales Value by Type
3.2.1 Global Parenteral Excipients Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Parenteral Excipients Sales Value, by Type (2019-2030)
3.2.3 Global Parenteral Excipients Sales Value, by Type (%) (2019-2030)
3.3 Global Parenteral Excipients Sales Volume by Type
3.3.1 Global Parenteral Excipients Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Parenteral Excipients Sales Volume, by Type (2019-2030)
3.3.3 Global Parenteral Excipients Sales Volume, by Type (%) (2019-2030)
3.4 Global Parenteral Excipients Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Precision Medicine
4.1.2 Biopharmaceuticals
4.1.3 Others
4.2 Global Parenteral Excipients Sales Value by Application
4.2.1 Global Parenteral Excipients Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Parenteral Excipients Sales Value, by Application (2019-2030)
4.2.3 Global Parenteral Excipients Sales Value, by Application (%) (2019-2030)
4.3 Global Parenteral Excipients Sales Volume by Application
4.3.1 Global Parenteral Excipients Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Parenteral Excipients Sales Volume, by Application (2019-2030)
4.3.3 Global Parenteral Excipients Sales Volume, by Application (%) (2019-2030)
4.4 Global Parenteral Excipients Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Parenteral Excipients Sales Value by Region
5.1.1 Global Parenteral Excipients Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Parenteral Excipients Sales Value by Region (2019-2024)
5.1.3 Global Parenteral Excipients Sales Value by Region (2025-2030)
5.1.4 Global Parenteral Excipients Sales Value by Region (%), (2019-2030)
5.2 Global Parenteral Excipients Sales Volume by Region
5.2.1 Global Parenteral Excipients Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Parenteral Excipients Sales Volume by Region (2019-2024)
5.2.3 Global Parenteral Excipients Sales Volume by Region (2025-2030)
5.2.4 Global Parenteral Excipients Sales Volume by Region (%), (2019-2030)
5.3 Global Parenteral Excipients Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Parenteral Excipients Sales Value, 2019-2030
5.4.2 North America Parenteral Excipients Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Parenteral Excipients Sales Value, 2019-2030
5.5.2 Europe Parenteral Excipients Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Parenteral Excipients Sales Value, 2019-2030
5.6.2 Asia Pacific Parenteral Excipients Sales Value by Region (%), 2023 VS 2030
5.7 South America
5.7.1 South America Parenteral Excipients Sales Value, 2019-2030
5.7.2 South America Parenteral Excipients Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Parenteral Excipients Sales Value, 2019-2030
5.8.2 Middle East & Africa Parenteral Excipients Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Parenteral Excipients Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Parenteral Excipients Sales Value
6.2.1 Key Countries/Regions Parenteral Excipients Sales Value, 2019-2030
6.2.2 Key Countries/Regions Parenteral Excipients Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Parenteral Excipients Sales Value, 2019-2030
6.3.2 United States Parenteral Excipients Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Parenteral Excipients Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Parenteral Excipients Sales Value, 2019-2030
6.4.2 Europe Parenteral Excipients Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Parenteral Excipients Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Parenteral Excipients Sales Value, 2019-2030
6.5.2 China Parenteral Excipients Sales Value by Type (%), 2023 VS 2030
6.5.3 China Parenteral Excipients Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Parenteral Excipients Sales Value, 2019-2030
6.6.2 Japan Parenteral Excipients Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Parenteral Excipients Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Parenteral Excipients Sales Value, 2019-2030
6.7.2 South Korea Parenteral Excipients Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Parenteral Excipients Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Parenteral Excipients Sales Value, 2019-2030
6.8.2 Southeast Asia Parenteral Excipients Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Parenteral Excipients Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Parenteral Excipients Sales Value, 2019-2030
6.9.2 India Parenteral Excipients Sales Value by Type (%), 2023 VS 2030
6.9.3 India Parenteral Excipients Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Merck
7.1.1 Merck Company Information
7.1.2 Merck Introduction and Business Overview
7.1.3 Merck Parenteral Excipients Sales, Revenue, Price and Gross Margin (2019-2024)
7.1.4 Merck Parenteral Excipients Product Offerings
7.1.5 Merck Recent Development
7.2 Ashland
7.2.1 Ashland Company Information
7.2.2 Ashland Introduction and Business Overview
7.2.3 Ashland Parenteral Excipients Sales, Revenue, Price and Gross Margin (2019-2024)
7.2.4 Ashland Parenteral Excipients Product Offerings
7.2.5 Ashland Recent Development
7.3 Roquette
7.3.1 Roquette Company Information
7.3.2 Roquette Introduction and Business Overview
7.3.3 Roquette Parenteral Excipients Sales, Revenue, Price and Gross Margin (2019-2024)
7.3.4 Roquette Parenteral Excipients Product Offerings
7.3.5 Roquette Recent Development
7.4 Croda Pharma
7.4.1 Croda Pharma Company Information
7.4.2 Croda Pharma Introduction and Business Overview
7.4.3 Croda Pharma Parenteral Excipients Sales, Revenue, Price and Gross Margin (2019-2024)
7.4.4 Croda Pharma Parenteral Excipients Product Offerings
7.4.5 Croda Pharma Recent Development
7.5 BASF
7.5.1 BASF Company Information
7.5.2 BASF Introduction and Business Overview
7.5.3 BASF Parenteral Excipients Sales, Revenue, Price and Gross Margin (2019-2024)
7.5.4 BASF Parenteral Excipients Product Offerings
7.5.5 BASF Recent Development
7.6 Evonik
7.6.1 Evonik Company Information
7.6.2 Evonik Introduction and Business Overview
7.6.3 Evonik Parenteral Excipients Sales, Revenue, Price and Gross Margin (2019-2024)
7.6.4 Evonik Parenteral Excipients Product Offerings
7.6.5 Evonik Recent Development
7.7 Seppic
7.7.1 Seppic Company Information
7.7.2 Seppic Introduction and Business Overview
7.7.3 Seppic Parenteral Excipients Sales, Revenue, Price and Gross Margin (2019-2024)
7.7.4 Seppic Parenteral Excipients Product Offerings
7.7.5 Seppic Recent Development
7.8 Lubrizol
7.8.1 Lubrizol Company Information
7.8.2 Lubrizol Introduction and Business Overview
7.8.3 Lubrizol Parenteral Excipients Sales, Revenue, Price and Gross Margin (2019-2024)
7.8.4 Lubrizol Parenteral Excipients Product Offerings
7.8.5 Lubrizol Recent Development
7.9 Pfanstiehl
7.9.1 Pfanstiehl Company Information
7.9.2 Pfanstiehl Introduction and Business Overview
7.9.3 Pfanstiehl Parenteral Excipients Sales, Revenue, Price and Gross Margin (2019-2024)
7.9.4 Pfanstiehl Parenteral Excipients Product Offerings
7.9.5 Pfanstiehl Recent Development
8 Industry Chain Analysis
8.1 Parenteral Excipients Industrial Chain
8.2 Parenteral Excipients Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Parenteral Excipients Sales Model
8.5.2 Sales Channel
8.5.3 Parenteral Excipients Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Parenteral Excipients market is projected to grow from US$ 1067 million in 2025 to US$ 1534 million by 2032, at a CAGR of 5.3% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-04-28
Pages: 138
USD 4900.00
(Single User License)
The global Parenteral Excipients market size was US$ 1067 million in 2025 and is forecast to reach a readjusted size of US$ 1534 million by 2032 with a CAGR of 5.3% during the forecast period 2026-2032.
Published Date: 2026-04-28
Pages: 135
USD 4250.00
(Single User License)
The global market for Parenteral Excipients was estimated to be worth US$ 1067 million in 2025 and is projected to reach US$ 1534 million, growing at a CAGR of 5.3% from 2026 to 2032.
Published Date: 2026-04-28
Pages: 130
USD 3950.00
(Single User License)
The global Parenteral Excipients market was valued at US$ 1067 million in 2025 and is anticipated to reach US$ 1534 million by 2032, at a CAGR of 5.3% from 2026 to 2032.
Published Date: 2026-04-28
Pages: 108
USD 2900.00
(Single User License)
The global Parenteral Excipients market is projected to grow from US$ 1588 million in 2024 to US$ 2283 million by 2031, at a CAGR of 5.4% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-07-31
Pages: 136
USD 4900.00
(Single User License)
The global market for Parenteral Excipients was estimated to be worth US$ 1588 million in 2024 and is forecast to a readjusted size of US$ 2283 million by 2031 with a CAGR of 5.4% during the forecast period 2025-2031.
Published Date: 2025-03-13
Pages: 108
USD 3950.00
(Single User License)
The global Parenteral Excipients market size was US$ 1588 million in 2024 and is forecast to a readjusted size of US$ 2283 million by 2031 with a CAGR of 5.4% during the forecast period 2025-2031.
Published Date: 2025-03-13
Pages: 78
USD 4250.00
(Single User License)
The global market for Parenteral Excipients was valued at US$ 1588 million in the year 2024 and is projected to reach a revised size of US$ 2283 million by 2031, growing at a CAGR of 5.4% during the forecast period.
Published Date: 2025-03-13
Pages: 83
USD 2900.00
(Single User License)
The global market for Parenteral Excipients was estimated to be worth US$ 1588 million in 2024 and is forecast to a readjusted size of US$ 2283 million by 2031 with a CAGR of 5.4% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 92
USD 3950.00
(Single User License)
The global market for Parenteral Excipients was valued at US$ 1547 million in the year 2023 and is projected to reach a revised size of US$ 2177 million by 2030, growing at a CAGR of 5.4% during the forecast period.
Published Date: 2025-01-04
Pages: 86
USD 2900.00
(Single User License)
The global Parenteral Excipients market is projected to grow from US$ 1067 million in 2025 to US$ 1534 million by 2032, at a CAGR of 5.3% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-04-28
Pages: 138
The global Parenteral Excipients market size was US$ 1067 million in 2025 and is forecast to reach a readjusted size of US$ 1534 million by 2032 with a CAGR of 5.3% during the forecast period 2026-2032.
Published: 2026-04-28
Pages: 135
The global market for Parenteral Excipients was estimated to be worth US$ 1067 million in 2025 and is projected to reach US$ 1534 million, growing at a CAGR of 5.3% from 2026 to 2032.
Published: 2026-04-28
Pages: 130
The global Parenteral Excipients market was valued at US$ 1067 million in 2025 and is anticipated to reach US$ 1534 million by 2032, at a CAGR of 5.3% from 2026 to 2032.
Published: 2026-04-28
Pages: 108
The global Parenteral Excipients market is projected to grow from US$ 1588 million in 2024 to US$ 2283 million by 2031, at a CAGR of 5.4% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-07-31
Pages: 136
The global market for Parenteral Excipients was estimated to be worth US$ 1588 million in 2024 and is forecast to a readjusted size of US$ 2283 million by 2031 with a CAGR of 5.4% during the forecast period 2025-2031.
Published: 2025-03-13
Pages: 108
The global Parenteral Excipients market size was US$ 1588 million in 2024 and is forecast to a readjusted size of US$ 2283 million by 2031 with a CAGR of 5.4% during the forecast period 2025-2031.
Published: 2025-03-13
Pages: 78
The global market for Parenteral Excipients was valued at US$ 1588 million in the year 2024 and is projected to reach a revised size of US$ 2283 million by 2031, growing at a CAGR of 5.4% during the forecast period.
Published: 2025-03-13
Pages: 83
The global market for Parenteral Excipients was estimated to be worth US$ 1588 million in 2024 and is forecast to a readjusted size of US$ 2283 million by 2031 with a CAGR of 5.4% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 92
The global market for Parenteral Excipients was valued at US$ 1547 million in the year 2023 and is projected to reach a revised size of US$ 2177 million by 2030, growing at a CAGR of 5.4% during the forecast period.
Published: 2025-01-04
Pages: 86
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now